A detailed history of Paulson Wealth Management Inc. transactions in Abb Vie Inc. stock. As of the latest transaction made, Paulson Wealth Management Inc. holds 6,394 shares of ABBV stock, worth $1.05 Million. This represents 0.34% of its overall portfolio holdings.

Number of Shares
6,394
Previous 7,094 9.87%
Holding current value
$1.05 Million
Previous $1.22 Million 3.78%
% of portfolio
0.34%
Previous 0.36%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 05, 2024

SELL
$163.84 - $199.33 $114,688 - $139,531
-700 Reduced 9.87%
6,394 $1.26 Million
Q2 2024

Jul 25, 2024

SELL
$154.79 - $180.76 $35,911 - $41,936
-232 Reduced 3.17%
7,094 $1.22 Million
Q1 2024

May 03, 2024

SELL
$159.82 - $182.1 $11,507 - $13,111
-72 Reduced 0.97%
7,326 $1.33 Million
Q4 2023

Feb 13, 2024

SELL
$137.6 - $154.97 $152,460 - $171,706
-1,108 Reduced 13.03%
7,398 $1.15 Million
Q3 2023

Nov 01, 2023

BUY
$133.59 - $154.65 $126,108 - $145,989
944 Added 12.48%
8,506 $1.27 Million
Q2 2023

Aug 01, 2023

BUY
$132.51 - $164.9 $137,280 - $170,836
1,036 Added 15.87%
7,562 $1.02 Million
Q1 2023

May 09, 2023

BUY
$144.61 - $166.54 $15,473 - $17,819
107 Added 1.67%
6,526 $1.04 Million
Q4 2022

Jan 26, 2023

SELL
$138.31 - $165.87 $5,394 - $6,468
-39 Reduced 0.6%
6,419 $0
Q3 2022

Nov 02, 2022

BUY
$134.21 - $153.93 $866,728 - $994,079
6,458 New
6,458 $867,000
Q4 2021

Jan 28, 2022

SELL
$107.43 - $135.93 $727,086 - $919,974
-6,768 Closed
0 $0
Q3 2021

Oct 22, 2021

BUY
$106.4 - $120.78 $1,489 - $1,690
14 Added 0.21%
6,768 $730,000
Q2 2021

Jul 26, 2021

BUY
$105.21 - $117.21 $20,305 - $22,621
193 Added 2.94%
6,754 $761,000
Q1 2021

Apr 30, 2021

BUY
$102.3 - $112.62 $14,015 - $15,428
137 Added 2.13%
6,561 $701,000
Q4 2020

Feb 05, 2021

BUY
$80.49 - $108.67 $35,737 - $48,249
444 Added 7.42%
6,424 $688,000
Q3 2020

Oct 14, 2020

BUY
$85.91 - $100.83 $37,542 - $44,062
437 Added 7.88%
5,980 $524,000
Q2 2020

Jul 17, 2020

BUY
$73.37 - $98.18 $14,967 - $20,028
204 Added 3.82%
5,543 $544,000
Q1 2020

Apr 29, 2020

BUY
$64.5 - $97.79 $19,414 - $29,434
301 Added 5.97%
5,339 $437,000
Q4 2019

Jan 21, 2020

BUY
$72.13 - $90.25 $9,016 - $11,281
125 Added 2.54%
5,038 $443,000
Q3 2019

Oct 30, 2019

SELL
$62.98 - $75.72 $10,895 - $13,099
-173 Reduced 3.4%
4,913 $372,000
Q2 2019

Jul 30, 2019

BUY
$65.7 - $83.98 $6,372 - $8,146
97 Added 1.94%
5,086 $344,000
Q1 2019

Apr 24, 2019

SELL
$77.14 - $90.79 $6,556 - $7,717
-85 Reduced 1.68%
4,989 $402,000
Q4 2018

Jan 23, 2019

SELL
$77.85 - $96.01 $214,087 - $264,027
-2,750 Reduced 35.15%
5,074 $450,000
Q3 2018

Oct 26, 2018

SELL
$88.91 - $98.84 $30,140 - $33,506
-339 Reduced 4.15%
7,824 $649,000
Q2 2018

Aug 01, 2018

SELL
$89.78 - $106.23 $11,581 - $13,703
-129 Reduced 1.56%
8,163 $756,000
Q1 2018

May 02, 2018

SELL
$92.01 - $123.21 $86,213 - $115,447
-937 Reduced 10.15%
8,292 $785,000
Q4 2017

Mar 01, 2018

BUY
$89.56 - $98.21 $826,549 - $906,380
9,229
9,229 $893,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $292B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Paulson Wealth Management Inc. Portfolio

Follow Paulson Wealth Management Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Paulson Wealth Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Paulson Wealth Management Inc. with notifications on news.